A detailed history of Jane Street Group, LLC transactions in Cerus Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 297,550 shares of CERS stock, worth $535,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares
297,550
Previous 373,033 20.23%
Holding current value
$535,590
Previous $656,000 21.19%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.7 - $2.39 $128,321 - $180,404
-75,483 Reduced 20.23%
297,550 $517,000
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.04 $339,114 - $427,033
209,330 Added 127.87%
373,033 $656,000
Q1 2024

May 15, 2024

SELL
$1.66 - $2.42 $561,785 - $818,988
-338,425 Reduced 67.4%
163,703 $309,000
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $627,660 - $1.18 Million
502,128 New
502,128 $1.08 Million
Q2 2023

Aug 14, 2023

BUY
$1.79 - $2.9 $260,931 - $422,738
145,772 Added 213.2%
214,145 $526,000
Q1 2023

May 15, 2023

BUY
$2.65 - $3.81 $52,814 - $75,933
19,930 Added 41.14%
68,373 $203,000
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $43,645 - $54,492
-12,913 Reduced 21.05%
48,443 $176,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $141,171 - $239,951
41,158 Added 203.77%
61,356 $221,000
Q2 2022

Aug 16, 2022

SELL
$4.41 - $5.69 $389,336 - $502,341
-88,285 Reduced 81.38%
20,198 $107,000
Q4 2021

Feb 15, 2022

BUY
$5.97 - $7.93 $429,881 - $571,015
72,007 Added 197.41%
108,483 $739,000
Q3 2021

Nov 16, 2021

BUY
$4.79 - $6.68 $28,102 - $39,191
5,867 Added 19.17%
36,476 $222,000
Q2 2021

Aug 16, 2021

SELL
$5.35 - $6.35 $255,687 - $303,479
-47,792 Reduced 60.96%
30,609 $181,000
Q1 2021

May 18, 2021

SELL
$5.68 - $7.87 $493,041 - $683,139
-86,803 Reduced 52.54%
78,401 $471,000
Q4 2020

Feb 17, 2021

BUY
$5.25 - $8.56 $645,314 - $1.05 Million
122,917 Added 290.67%
165,204 $1.14 Million
Q3 2020

Nov 17, 2020

BUY
$5.78 - $7.47 $140,407 - $181,461
24,292 Added 134.99%
42,287 $264,000
Q2 2020

Aug 17, 2020

BUY
$4.5 - $7.02 $14,935 - $23,299
3,319 Added 22.62%
17,995 $120,000
Q1 2020

May 15, 2020

BUY
$2.87 - $5.49 $42,120 - $80,571
14,676 New
14,676 $68,000
Q3 2019

Nov 14, 2019

SELL
$4.86 - $6.05 $80,821 - $100,611
-16,630 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$4.51 - $6.6 $75,001 - $109,758
16,630 New
16,630 $93,000
Q2 2018

Aug 15, 2018

SELL
$5.19 - $7.25 $101,137 - $141,280
-19,487 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$3.56 - $5.74 $69,373 - $111,855
19,487 New
19,487 $107,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $319M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.